ScreenerHero

LFCR Lifecore Biomedical, Inc.

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · lifecore.com
6.440USD-0.15%Mkt Cap: 244.11M $P/E: —

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internati…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap244.11M USD
Enterprise Value433.47M USD
Revenue (TTM)129.46M USD
Gross Profit40.30M USD
Net Income (TTM)-38.72M USD
Revenue/Share3.46 USD
Last Price6.440 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees382
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-8.27
PEG2.66
EV/EBITDA52.59
EV/Revenue3.35
P/S1.89
P/B-7.13
EPS (TTM)-1.27
EPS (Forward)-0.78
52W Range
3.63053% of range8.980
52W High8.980 USD
52W Low3.630 USD
Profitability
Gross Margin31.27%
Oper. Margin7.51%
EBITDA Margin6.37%
Profit Margin-30.04%
ROE272.62%
ROA-16.68%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-206.00K USD
CapEx (TTM)13.41M USD
FCF Margin—
FCF Yield—
Net Debt139.13M USD
Net Debt/EBITDA16.88
Balance Sheet
Debt/Equity-10.04
Current Ratio3.49
Quick Ratio2.18
Book Value/Sh-0.90 USD
Cash/Share0.46 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating3.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)6.280 USD
Upside (mean)-2.5%
Target Range6.280 USD – 6.280 USD
# Analysts1
Ownership
Shares Out.37.91M
Float19.34M
Insiders3.04%
Institutions72.50%
Short Interest
Short Ratio19.5d
Short % Float8.66%
Short % Out.7.05%
Shares Short2.67M
Short (prev mo.)2.42M
Technical
SMA 504.752 (+35.5%)
SMA 2005.650 (+14.0%)
Beta0.98
S&P 52W Chg16.45%
Avg Vol (30d)465.28K
Avg Vol (10d)931.79K
Technical Indicators
RSI (14)73.7
MACD0.5552
MACD Signal0.3788
MACD Hist.+0.1764
BB Upper7.443 USD
BB Middle5.176 USD
BB Lower2.909 USD
BB Width87.60%
ATR (14)0.2634 USD
Vol Ratio (20d)3.09x